| UniProt ID | NOP16_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y3C1 | |
| Protein Name | Nucleolar protein 16 | |
| Gene Name | NOP16 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 178 | |
| Subcellular Localization | Nucleus, nucleolus . | |
| Protein Description | ||
| Protein Sequence | MPKAKGKTRRQKFGYSVNRKRLNRNARRKAAPRIECSHIRHAWDHAKSVRQNLAEMGLAVDPNRAVPLRKRKVKAMEVDIEERPKELVRKPYVLNDLEAEASLPEKKGNTLSRDLIDYVRYMVENHGEDYKAMARDEKNYYQDTPKQIRSKINVYKRFYPAEWQDFLDSLQKRKMEVE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 8 | Phosphorylation | MPKAKGKTRRQKFGY CCCCCCCCCHHHHCC | 39.49 | 21406692 | |
| 12 | Ubiquitination | KGKTRRQKFGYSVNR CCCCCHHHHCCCCCH | 38.66 | - | |
| 15 | Phosphorylation | TRRQKFGYSVNRKRL CCHHHHCCCCCHHHH | 16.75 | 28152594 | |
| 16 | Phosphorylation | RRQKFGYSVNRKRLN CHHHHCCCCCHHHHC | 17.19 | 25159151 | |
| 47 | 2-Hydroxyisobutyrylation | RHAWDHAKSVRQNLA HHHHHHHHHHHHHHH | 46.17 | - | |
| 47 | Acetylation | RHAWDHAKSVRQNLA HHHHHHHHHHHHHHH | 46.17 | 26822725 | |
| 47 | Ubiquitination | RHAWDHAKSVRQNLA HHHHHHHHHHHHHHH | 46.17 | - | |
| 48 | Phosphorylation | HAWDHAKSVRQNLAE HHHHHHHHHHHHHHH | 24.26 | 26434776 | |
| 74 | Sumoylation | PLRKRKVKAMEVDIE CCCCCCCCEEECCHH | 45.08 | 28112733 | |
| 76 | Sulfoxidation | RKRKVKAMEVDIEER CCCCCCEEECCHHHC | 4.23 | 21406390 | |
| 77 | Acetylation | KRKVKAMEVDIEERP CCCCCEEECCHHHCC | 41.73 | 19608861 | |
| 90 | Ubiquitination | RPKELVRKPYVLNDL CCHHHHCCCCCCCCH | 32.97 | 19608861 | |
| 90 | Acetylation | RPKELVRKPYVLNDL CCHHHHCCCCCCCCH | 32.97 | 19608861 | |
| 92 | Phosphorylation | KELVRKPYVLNDLEA HHHHCCCCCCCCHHH | 22.17 | 28152594 | |
| 102 | Phosphorylation | NDLEAEASLPEKKGN CCHHHHHCCCCCCCC | 35.64 | 28450419 | |
| 106 | Ubiquitination | AEASLPEKKGNTLSR HHHCCCCCCCCCCCH | 65.13 | - | |
| 106 | Acetylation | AEASLPEKKGNTLSR HHHCCCCCCCCCCCH | 65.13 | 26051181 | |
| 106 | 2-Hydroxyisobutyrylation | AEASLPEKKGNTLSR HHHCCCCCCCCCCCH | 65.13 | - | |
| 112 | Phosphorylation | EKKGNTLSRDLIDYV CCCCCCCCHHHHHHH | 23.01 | 29214152 | |
| 130 | Phosphorylation | VENHGEDYKAMARDE HHHCCHHHHHHHHHC | 9.06 | - | |
| 131 | Acetylation | ENHGEDYKAMARDEK HHCCHHHHHHHHHCC | 43.96 | 26051181 | |
| 134 (in isoform 2) | Ubiquitination | - | 22.19 | - | |
| 135 | Ubiquitination | EDYKAMARDEKNYYQ HHHHHHHHHCCCCCC | 39.27 | - | |
| 138 | 2-Hydroxyisobutyrylation | KAMARDEKNYYQDTP HHHHHHCCCCCCCCH | 55.31 | - | |
| 138 | Acetylation | KAMARDEKNYYQDTP HHHHHHCCCCCCCCH | 55.31 | 26051181 | |
| 140 | Phosphorylation | MARDEKNYYQDTPKQ HHHHCCCCCCCCHHH | 17.36 | 27174698 | |
| 141 | Phosphorylation | ARDEKNYYQDTPKQI HHHCCCCCCCCHHHH | 14.87 | 27174698 | |
| 144 | Phosphorylation | EKNYYQDTPKQIRSK CCCCCCCCHHHHHHH | 19.50 | 25159151 | |
| 146 | Malonylation | NYYQDTPKQIRSKIN CCCCCCHHHHHHHHH | 61.52 | 26320211 | |
| 146 | Acetylation | NYYQDTPKQIRSKIN CCCCCCHHHHHHHHH | 61.52 | 26051181 | |
| 146 | Ubiquitination | NYYQDTPKQIRSKIN CCCCCCHHHHHHHHH | 61.52 | - | |
| 169 | Phosphorylation | EWQDFLDSLQKRKME HHHHHHHHHHHHHHC | 34.54 | 22199227 | |
| 216 (in isoform 3) | Phosphorylation | - | 28674419 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NOP16_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NOP16_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NOP16_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| HERC5_HUMAN | HERC5 | physical | 28514442 | |
| NP1L1_HUMAN | NAP1L1 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-90, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16 AND THR-144, AND MASSSPECTROMETRY. | |